Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Staaf, Johan"'
Autor:
Karadzovska-Kotevska M; Department of Respiratory Diseases and Allergology, Skåne University Hospital Lund, Lund, Sweden.; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden., Brunnström H; Division of Laboratory Medicine, Department of Genetics and Pathology, Region Skåne, Lund, Sweden.; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Kosieradzki J; Department of Respiratory Diseases and Allergology, Skåne University Hospital Lund, Lund, Sweden., Ek L; Department of Respiratory Diseases and Allergology, Skåne University Hospital Lund, Lund, Sweden., Estberg C; Department of Respiratory Diseases and Allergology, Skåne University Hospital Lund, Lund, Sweden., Staaf J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden., Barath S; Department of Respiratory Diseases and Allergology, Skåne University Hospital Lund, Lund, Sweden., Planck M; Department of Respiratory Diseases and Allergology, Skåne University Hospital Lund, Lund, Sweden.; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden.
Publikováno v:
PloS one [PLoS One] 2022 Feb 02; Vol. 17 (2), pp. e0263342. Date of Electronic Publication: 2022 Feb 02 (Print Publication: 2022).
Autor:
Glodzik D; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden.; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA, Cambridge, UK.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bosch A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden.; Department of Oncology, Skåne University Hospital, SE-22184, Lund, Sweden., Hartman J; Department of Oncology and Pathology, Karolinska Institute, SE-17177, Stockholm, Sweden., Aine M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden.; Division of Molecular Hematology, Department of Laboratory Medicine, Lund University, SE-22184, Lund, Sweden., Vallon-Christersson J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Reuterswärd C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Karlsson A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Mitra S; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Niméus E; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden.; Division of Surgery, Department of Clinical Sciences, Lund University, SE-22184, Lund, Sweden., Holm K; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Häkkinen J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Hegardt C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Saal LH; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Larsson C; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, SE-22381, Lund, Sweden., Malmberg M; Department of Oncology, Skåne University Hospital, SE-22184, Lund, Sweden., Rydén L; Division of Surgery, Department of Clinical Sciences, Lund University, SE-22184, Lund, Sweden., Ehinger A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden.; Department of Genetics and Pathology, Laboratory Medicine, Region Skåne, SE-22184, Lund, Sweden., Loman N; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden.; Department of Oncology, Skåne University Hospital, SE-22184, Lund, Sweden., Kvist A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Ehrencrona H; Department of Genetics and Pathology, Laboratory Medicine, Region Skåne, SE-22184, Lund, Sweden.; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, SE-22184, Lund, Sweden., Nik-Zainal S; Academic Department of Medical Genetics, The Clinical School University of Cambridge, Cambridge Biomedical Research Campus, CB2 0QQ, Cambridge, UK., Borg Å; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden., Staaf J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE-22381, Lund, Sweden. johan.staaf@med.lu.se.
Publikováno v:
Nature communications [Nat Commun] 2020 Jul 27; Vol. 11 (1), pp. 3747. Date of Electronic Publication: 2020 Jul 27.
Autor:
Karlsson J; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Valind A; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Holmquist Mengelbier L; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Bredin S; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Cornmark L; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Jansson C; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Wali A; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Viklund B; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Øra I; Division of Pediatric Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Börjesson A; Division of Pediatric Surgery, Department of Clinical Sciences, Lund University, Lund, Sweden., Backman T; Division of Pediatric Surgery, Department of Clinical Sciences, Lund University, Lund, Sweden., Braekeveldt N; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden., Sandstedt B; Division of Pediatric Oncology and the Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden., Pal N; Division of Pediatric Oncology and the Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden., Isaksson A; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Lackner BG; Department of Pathology, Laboratory Medicine, Medical Services Skåne, Lund, Sweden., Jonson T; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Bexell D; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.; Department of Pathology, Laboratory Medicine, Medical Services Skåne, Lund, Sweden., Gisselsson D; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden. david.gisselsson_nord@med.lu.se.; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. david.gisselsson_nord@med.lu.se.; Department of Pathology, Laboratory Medicine, Medical Services Skåne, Lund, Sweden. david.gisselsson_nord@med.lu.se.
Publikováno v:
Nature genetics [Nat Genet] 2018 Jul; Vol. 50 (7), pp. 944-950. Date of Electronic Publication: 2018 Jun 04.
Autor:
Lindquist KE; Department of Pathology, Regional Laboratories Region Skåne, Lund SE 22185, Sweden., Karlsson A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden., Levéen P; Department of Pathology, Regional Laboratories Region Skåne, Lund SE 22185, Sweden., Brunnström H; Department of Pathology, Regional Laboratories Region Skåne, Lund SE 22185, Sweden.; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE 22185, Sweden., Reuterswärd C; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden., Holm K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden., Jönsson M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden., Annersten K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden., Rosengren F; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden., Jirström K; Department of Pathology, Regional Laboratories Region Skåne, Lund SE 22185, Sweden.; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE 22185, Sweden., Kosieradzki J; Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund SE22185, Sweden., Ek L; Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund SE22185, Sweden., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden.; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, Lund SE 22381, Sweden., Planck M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden.; Department of Oncology, Skåne University Hospital, Lund SE 22381, Sweden., Jönsson G; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden.; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, Lund SE 22381, Sweden., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund SE 22381, Sweden.; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, Lund SE 22381, Sweden.
Publikováno v:
Oncotarget [Oncotarget] 2017 May 23; Vol. 8 (21), pp. 34796-34810.
Autor:
Davies H; Wellcome Trust Sanger Institute, Hinxton, UK., Glodzik D; Wellcome Trust Sanger Institute, Hinxton, UK., Morganella S; Wellcome Trust Sanger Institute, Hinxton, UK., Yates LR; Wellcome Trust Sanger Institute, Hinxton, UK.; Guy's and St Thomas' NHS Trust, London, UK., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Zou X; Wellcome Trust Sanger Institute, Hinxton, UK., Ramakrishna M; Wellcome Trust Sanger Institute, Hinxton, UK.; Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK., Martin S; Wellcome Trust Sanger Institute, Hinxton, UK., Boyault S; Translational Research Lab Department, Centre Léon Bérard, Lyon, France., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Simpson PT; Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia., King TA; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Raine K; Wellcome Trust Sanger Institute, Hinxton, UK., Eyfjord JE; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK., Stunnenberg HG; Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands., van de Vijver MJ; Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands., Span PN; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Lakhani SR; Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Vincent-Salomon A; Department of Pathology, Institut Curie, Paris, France.; INSERM U934, Institut Curie, Paris, France., Sotiriou C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium., Tutt A; Breast Cancer Now Research Unit, King's College, London, UK.; Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK., Thompson AM; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Van Laere S; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; HistoGeneX, Wilrijk, Belgium., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Viari A; Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France.; Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France., Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, UK., Stratton MR; Wellcome Trust Sanger Institute, Hinxton, UK., Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, UK.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Publikováno v:
Nature medicine [Nat Med] 2017 Apr; Vol. 23 (4), pp. 517-525. Date of Electronic Publication: 2017 Mar 13.
Autor:
Cirenajwis H; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden., Lauss M; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden., Ekedahl H; Division of Surgery, Department of Clinical Sciences, Lund University, Sweden., Törngren T; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden., Kvist A; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden., Saal LH; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden., Olsson H; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden.; Department of Oncology, Skåne University Hospital, Lund University, Sweden., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden., Carneiro A; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden.; Department of Oncology, Skåne University Hospital, Lund University, Sweden., Ingvar C; Division of Surgery, Department of Clinical Sciences, Lund University, Sweden., Harbst K; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden., Hayward NK; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Jönsson G; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Sweden.
Publikováno v:
Molecular oncology [Mol Oncol] 2017 Apr; Vol. 11 (4), pp. 438-451. Date of Electronic Publication: 2017 Mar 24.
Autor:
Glodzik D; Wellcome Trust Sanger Institute, Cambridge, UK., Morganella S; Wellcome Trust Sanger Institute, Cambridge, UK., Davies H; Wellcome Trust Sanger Institute, Cambridge, UK., Simpson PT; The University of Queensland: UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, Australia., Li Y; Wellcome Trust Sanger Institute, Cambridge, UK., Zou X; Wellcome Trust Sanger Institute, Cambridge, UK., Diez-Perez J; Wellcome Trust Sanger Institute, Cambridge, UK., Staaf J; Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden., Alexandrov LB; Wellcome Trust Sanger Institute, Cambridge, UK.; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, USA.; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, USA., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., Brinkman AB; Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands., Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Russnes H; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Raine K; Wellcome Trust Sanger Institute, Cambridge, UK., Purdie CA; Department of Pathology, Ninewells Hospital &Medical School, Dundee, UK., Lakhani SR; The University of Queensland: UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, Australia.; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Thompson AM; Department of Pathology, Ninewells Hospital &Medical School, Dundee, UK.; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridgeshire, UK., Stunnenberg HG; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., van de Vijver MJ; Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul, South Korea., Viari A; Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France.; Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France., Easton D; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Evan G; Department of Biochemistry, University of Cambridge, Cambridge, UK., Campbell PJ; Wellcome Trust Sanger Institute, Cambridge, UK., Stratton MR; Wellcome Trust Sanger Institute, Cambridge, UK., Nik-Zainal S; Wellcome Trust Sanger Institute, Cambridge, UK.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Publikováno v:
Nature genetics [Nat Genet] 2017 Mar; Vol. 49 (3), pp. 341-348. Date of Electronic Publication: 2017 Jan 23.
Autor:
Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK., Davies H; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden., Ramakrishna M; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Glodzik D; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Zou X; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Martincorena I; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Alexandrov LB; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA.; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA., Martin S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Wedge DC; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Van Loo P; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.; Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium., Ju YS; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands., Brinkman AB; Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands., Morganella S; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK., Aure MR; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway.; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway., Lingjærde OC; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway.; Department of Computer Science, University of Oslo, Oslo, Norway., Langerød A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway.; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway., Ringnér M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden., Ahn SM; Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea., Boyault S; Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France., Brock JE; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA., Broeks A; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Butler A; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Desmedt C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium., Dirix L; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Dronov S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Fatima A; Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands., Gerstung M; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Hooijer GK; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., Jang SJ; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea., Jones DR; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Kim HY; Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea., King TA; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA., Krishnamurthy S; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA., Lee HJ; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea., Lee JY; Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea., Li Y; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., McLaren S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Menzies A; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Mustonen V; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., O'Meara S; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Pauporté I; Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France., Pivot X; University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France., Purdie CA; Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK., Raine K; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Ramakrishnan K; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Rodríguez-González FG; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands., Romieu G; Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands., Simpson PT; The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia., Shepherd R; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Stebbings L; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Stefansson OA; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland., Teague J; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Tommasi S; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Treilleux I; Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France., Van den Eynden GG; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium., Vermeulen P; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium., Vincent-Salomon A; Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France., Yates L; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK., van't Veer L; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Tutt A; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK.; Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK., Knappskog S; Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.; Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway., Tan BK; National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore.; Singapore General Hospital, Outram Road, 169608, Singapore., Jonkers J; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden., Ueno NT; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA., Sotiriou C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium., Viari A; Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France.; Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France., Futreal PA; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.; Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA., Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Span PN; Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands., Van Laere S; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Lakhani SR; The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia.; Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia., Eyfjord JE; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland., Thompson AM; Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA., Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK., Stunnenberg HG; Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands., van de Vijver MJ; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway.; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA., Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea., Thomas G; Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France., Stratton MR; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.
Publikováno v:
Nature [Nature] 2016 Jun 02; Vol. 534 (7605), pp. 47-54. Date of Electronic Publication: 2016 May 02.
Autor:
Morganella S; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridgeshire CB10 1SD, UK., Alexandrov LB; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK.; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos NM 87545, New Mexico, USA.; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos NM 87545, New Mexico, USA., Glodzik D; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Zou X; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Davies H; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands., Brinkman AB; Radboud University, Faculty of Science, Department of Molecular Biology, 6525GA Nijmegen, The Netherlands., Martin S; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Ramakrishna M; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Butler A; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Kim HY; Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden., Sotiriou C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium., Futreal PA; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridgeshire CB10 1SD, UK.; Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA., Campbell PJ; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Span PN; Department of Radiation Oncology, and department of Laboratory Medicine, Radboud university medical center, Nijmegen 6525GA, The Netherlands., Van Laere S; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium and Center for Oncological Research, University of Antwerp, Antwerp B-2610, Belgium., Lakhani SR; Centre for Clinical Research and School of Medicine, University of Queensland, Brisbane, Queensland 4059, Australia.; Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia., Eyfjord JE; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland., Thompson AM; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street,Houston, Texas 77030, USA.; Department of Surgical Oncology, University of Dundee, Dundee DD1 9SY, UK., Stunnenberg HG; Radboud University, Faculty of Science, Department of Molecular Biology, 6525GA Nijmegen, The Netherlands., van de Vijver MJ; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA., Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea., Thomas G; Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France., Sale J; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK., Rada C; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK., Stratton MR; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK., Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridgeshire CB10 1SD, UK., Nik-Zainal S; Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK.
Publikováno v:
Nature communications [Nat Commun] 2016 May 02; Vol. 7, pp. 11383. Date of Electronic Publication: 2016 May 02.
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
Autor:
Karlsson A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden., Brunnström H; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE 22185 Lund, Sweden.; Department of Pathology, Regional Laboratories Region Skåne, SE 22185 Lund, Sweden., Lindquist KE; Department of Pathology, Regional Laboratories Region Skåne, SE 22185 Lund, Sweden., Jirström K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE 22185 Lund, Sweden.; Department of Pathology, Regional Laboratories Region Skåne, SE 22185 Lund, Sweden., Jönsson M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden., Rosengren F; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden., Reuterswärd C; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden., Cirenajwis H; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden.; Create Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, SE 22381 Lund, Sweden., Jönsson P; Department of Thoracic Surgery, Lund University, Skåne University Hospital, SE 22185 Lund, Sweden., Planck M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden.; Department of Oncology, Skåne University Hospital, SE 22185 Lund, Sweden., Jönsson G; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden.; Create Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, SE 22381 Lund, Sweden., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381 Lund, Sweden.; Create Health Strategic Center for Translational Cancer Research, Lund University, Medicon Village, SE 22381 Lund, Sweden.
Publikováno v:
Oncotarget [Oncotarget] 2015 Sep 08; Vol. 6 (26), pp. 22028-37.